Search
forResearch 10 of 427
- Docetaxel.
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer
- Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
- High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →